Showing results (301-310 of 3,079) with videos related to
Sort By:
Pageof 308
Drug Safety|January 20, 2017
Developing a Crowdsourcing Approach and Tool for Pharmacovigilance Education Material DeliveryAndrew Bate, Jürgen Beckmann, Alexander Dodoo, et al.Drug Safety|January 26, 2017
Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: A Prospective Cohort StudyTim Schutte, Jelle Tichelaar, Michael O Reumerman, et al.Drug Safety|February 12, 2017
Sensitivity of the UK Clinical Practice Research Datalink to Detect Neurodevelopmental Effects of Medicine Exposure in Utero: Comparative Analysis of an Antiepileptic Drug-Exposed CohortR A Charlton, A McGrogan, J Snowball, et al.Drug Safety|March 20, 2019
Summary of Torsades de Pointes (TdP) Reports Associated with Intravenous Drug Formulations Containing the Preservative ChlorobutanolR David Woosley, Klaus Romero, Craig W Heise, et al.Drug Safety|February 15, 2014
Effect of tyrosine kinase inhibitors on wound healing and tissue repair: implications for surgery in cancer patientsDevron R Shah, Shamik Dholakia, Rashmi R ShahDrug Safety|April 14, 2017
The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative AnalysisLeàn Rolfes, Florence van Hunsel, Laura van der Linden, et al.Drug Safety|June 19, 2008
Memantine for the treatment of Alzheimer's disease: tolerability and safety data from clinical trialsMartin R Farlow, Stephen M Graham, Gustavo AlvaDrug Safety|June 19, 2008
Safety of low-dose aprotinin in coronary artery bypass graft surgery: a single-centre investigation in 2,436 patients in GermanyMario Kluth, Jan U Lueth, Armin Zittermann, et al.Drug Safety|August 3, 2019
The Association between Metformin Therapy and Lactic AcidosisIsabelle H S Kuan, Ruth L Savage, Stephen B Duffull, et al.Drug Safety|December 10, 1997
A risk-benefit assessment of octreotide in the treatment of acromegalyA J van der Lely, W W de Herder, S W LambertsPageof 308